Response rates and survival in patients with head and neck cancer treated with a combination of cisplatin and 5-fluorouracil prior to radiotherapy
- 31 August 1988
- journal article
- research article
- Published by Elsevier in Clinical Radiology
- Vol. 39 (5) , 551-554
- https://doi.org/10.1016/s0009-9260(88)80235-6
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Integration of chemotherapy into the combined modality therapy of head and neck squamous cancerInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neckBritish Journal of Cancer, 1986
- A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.Journal of Clinical Oncology, 1985
- Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatinCancer, 1985
- Cisplatin-containing chemotherapy in advanced head and neck cancerClinical Radiology, 1985
- Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancerThe American Journal of Surgery, 1984
- Reporting results of cancer treatmentCancer, 1981